{
    "nctId": "NCT02304640",
    "briefTitle": "Prevalence, Severity and Determinants of Cancer-related Fatigue (CRF) in Asian Breast Cancer Patients",
    "officialTitle": "Prevalence, Severity and Determinants of Cancer-related Fatigue (CRF) in Asian Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Fatigue, Chemotherapy, Breast Cancer, Supportive Care",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 194,
    "primaryOutcomeMeasure": "Incidence of cancer-related fatigue",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* At least 21 years of age\n* Stage I-III breast cancer\n* Chinese, Malay or Indian ethnics\n* Surgical treatment has been performed\n* Scheduled to receive four cycles of chemotherapy (doxorubicin/cyclophosphamide \\[AC\\], docetaxel/cyclophosphamide \\[TC\\], 5-fluorouracil/epirubicin/cyclophosphamide \\[FEC\\]) (total duration of 3 months) and/or radiotherapy and/or hormonal therapy\n* No prior history of chemotherapy and/or radiotherapy\n* Able to read and understand either English or Mandarin\n\nExclusion Criteria:\n\n* Physically or mentally unable to provide verbal/written consent\n* Symptomatically ill (such as infection or an allergic reaction to chemotherapy)\n* Presence of another condition for which fatigue is a prominent symptom (e.g. AIDS, fibromyalgia, or rheumatoid arthritis)\n* Newly started on any medications that can cause general fatigue and body weakness (e.g. a beta-blocker or antidepressant, antihistamine, or antipsychotic medication)\n* Presence of neurologic or immune-related medical condition or behavior known to influence the immune system (e.g. smoking or heavy drinking)",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}